Trials / Recruiting
RecruitingNCT05079399
Biomarker of Diabetic Retinopathy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 192 (estimated)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Diabetic retinopathy (DR) is a complication of diabetes in which blood vessels supplying blood to the back of the eye (retina) are dysfunctional. This can lead to an improper supply of oxygen and nutrients to the retinal tissue, or it may trigger the formation of new blood vessels in response to the oxygen/nutrient deficiency. Ultimately affecting the normal vision. There is no known marker that will provide information on the health status of retinal blood vessels. Using highly specialized cells in the blood, this study will try to discover a marker of DR.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood draw | Blood samples will be collected via venipuncture |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2021-10-15
- Last updated
- 2025-05-01
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05079399. Inclusion in this directory is not an endorsement.